DCI - South Lexington is a medicare approved dialysis facility center in Lexington, Kentucky and it has 23 dialysis stations. It is located in Fayette county at 2374 Professional Heights Dr., Lexington, KY, 40503. You can reach out to the office of DCI - South Lexington at (859) 967-0400. This dialysis clinic is managed and/or owned by Dialysis Clinic, Inc.. DCI - South Lexington has the following ownership type - Non-Profit. It was first certified by medicare in February, 1986. The medicare id for this facility is 182512 and it accepts patients under medicare ESRD program.
| Name | DCI - South Lexington |
|---|---|
| Location | 2374 Professional Heights Dr., Lexington, Kentucky |
| No. of Dialysis Stations | 23 |
| Medicare ID | 182512 |
| Managed By | Dialysis Clinic, Inc. |
| Ownership Type | Non-Profit |
| Late Shifts | No |
| 2374 Professional Heights Dr., Lexington, Kentucky, 40503 | |
| (859) 967-0400 | |
News Archive
Merck, today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion under accelerated assessment recommending approval of the investigational medicine VICTRELIS (boceprevir) for the treatment of chronic hepatitis C virus genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients with compensated liver disease who are previously untreated or who have failed previous therapy.
Why do patients opt for complementary and alternative therapies when they are ill? Is the relationship and communication between a patient and a practitioner as important in the treatment as the complementary treatments prescribed?
A team of scientists led by a researcher at the Case Western Reserve University School of Medicine is making strides to fight deadly metastatic breast cancer by combining nanotechnology with immunotherapy.
A Supreme Court decision to throw out health-care reform on Commerce Clause grounds could open up hundreds of other federal laws to legal challenge - starting with the Civil Rights Act. It's hard to believe that this court really wants to relitigate the second half of the 20th century, but we'll have an answer soon enough.
› Verified 4 days ago
| NPI Number | 1841223229 |
| Doing Business As | Dialysis Clinic Inc. |
| Address | 2374 Professional Heights Drive Lexington, Kentucky, 40503 |
| Phone Number | (859) 967-0400 |
News Archive
Merck, today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion under accelerated assessment recommending approval of the investigational medicine VICTRELIS (boceprevir) for the treatment of chronic hepatitis C virus genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients with compensated liver disease who are previously untreated or who have failed previous therapy.
Why do patients opt for complementary and alternative therapies when they are ill? Is the relationship and communication between a patient and a practitioner as important in the treatment as the complementary treatments prescribed?
A team of scientists led by a researcher at the Case Western Reserve University School of Medicine is making strides to fight deadly metastatic breast cancer by combining nanotechnology with immunotherapy.
A Supreme Court decision to throw out health-care reform on Commerce Clause grounds could open up hundreds of other federal laws to legal challenge - starting with the Civil Rights Act. It's hard to believe that this court really wants to relitigate the second half of the 20th century, but we'll have an answer soon enough.
› Verified 4 days ago
| Dialysis patients with Hemoglobin data | 39 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 13 |
News Archive
Merck, today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion under accelerated assessment recommending approval of the investigational medicine VICTRELIS (boceprevir) for the treatment of chronic hepatitis C virus genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients with compensated liver disease who are previously untreated or who have failed previous therapy.
Why do patients opt for complementary and alternative therapies when they are ill? Is the relationship and communication between a patient and a practitioner as important in the treatment as the complementary treatments prescribed?
A team of scientists led by a researcher at the Case Western Reserve University School of Medicine is making strides to fight deadly metastatic breast cancer by combining nanotechnology with immunotherapy.
A Supreme Court decision to throw out health-care reform on Commerce Clause grounds could open up hundreds of other federal laws to legal challenge - starting with the Civil Rights Act. It's hard to believe that this court really wants to relitigate the second half of the 20th century, but we'll have an answer soon enough.
› Verified 4 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 57 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 520 |
| Percentage of adult patients getting regular hemodialysis at the center | 98 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Merck, today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion under accelerated assessment recommending approval of the investigational medicine VICTRELIS (boceprevir) for the treatment of chronic hepatitis C virus genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients with compensated liver disease who are previously untreated or who have failed previous therapy.
Why do patients opt for complementary and alternative therapies when they are ill? Is the relationship and communication between a patient and a practitioner as important in the treatment as the complementary treatments prescribed?
A team of scientists led by a researcher at the Case Western Reserve University School of Medicine is making strides to fight deadly metastatic breast cancer by combining nanotechnology with immunotherapy.
A Supreme Court decision to throw out health-care reform on Commerce Clause grounds could open up hundreds of other federal laws to legal challenge - starting with the Civil Rights Act. It's hard to believe that this court really wants to relitigate the second half of the 20th century, but we'll have an answer soon enough.
› Verified 4 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at DCI - South Lexington with elevated calcium levels.
| Patients with hypercalcemia | 64 |
| Hypercalcemia patient months | 566 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 65 |
| Patients with Serumphosphor less than 3.5 mg/dL | 9 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 20 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 25 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 28 |
| Patients with Serumphosphor greater than 7 mg/dL | 18 |
News Archive
Merck, today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion under accelerated assessment recommending approval of the investigational medicine VICTRELIS (boceprevir) for the treatment of chronic hepatitis C virus genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients with compensated liver disease who are previously untreated or who have failed previous therapy.
Why do patients opt for complementary and alternative therapies when they are ill? Is the relationship and communication between a patient and a practitioner as important in the treatment as the complementary treatments prescribed?
A team of scientists led by a researcher at the Case Western Reserve University School of Medicine is making strides to fight deadly metastatic breast cancer by combining nanotechnology with immunotherapy.
A Supreme Court decision to throw out health-care reform on Commerce Clause grounds could open up hundreds of other federal laws to legal challenge - starting with the Civil Rights Act. It's hard to believe that this court really wants to relitigate the second half of the 20th century, but we'll have an answer soon enough.
› Verified 4 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 59 |
| Patient months included in arterial venous fistula and catheter summaries | 470 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 63 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 9 |
News Archive
Merck, today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion under accelerated assessment recommending approval of the investigational medicine VICTRELIS (boceprevir) for the treatment of chronic hepatitis C virus genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients with compensated liver disease who are previously untreated or who have failed previous therapy.
Why do patients opt for complementary and alternative therapies when they are ill? Is the relationship and communication between a patient and a practitioner as important in the treatment as the complementary treatments prescribed?
A team of scientists led by a researcher at the Case Western Reserve University School of Medicine is making strides to fight deadly metastatic breast cancer by combining nanotechnology with immunotherapy.
A Supreme Court decision to throw out health-care reform on Commerce Clause grounds could open up hundreds of other federal laws to legal challenge - starting with the Civil Rights Act. It's hard to believe that this court really wants to relitigate the second half of the 20th century, but we'll have an answer soon enough.
› Verified 4 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 52 |
| Hospitalization Rate in facility | 162.4 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 290.4 |
| Hospitalization Rate: Lower Confidence Limit | 94.6 |
News Archive
Merck, today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion under accelerated assessment recommending approval of the investigational medicine VICTRELIS (boceprevir) for the treatment of chronic hepatitis C virus genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients with compensated liver disease who are previously untreated or who have failed previous therapy.
Why do patients opt for complementary and alternative therapies when they are ill? Is the relationship and communication between a patient and a practitioner as important in the treatment as the complementary treatments prescribed?
A team of scientists led by a researcher at the Case Western Reserve University School of Medicine is making strides to fight deadly metastatic breast cancer by combining nanotechnology with immunotherapy.
A Supreme Court decision to throw out health-care reform on Commerce Clause grounds could open up hundreds of other federal laws to legal challenge - starting with the Civil Rights Act. It's hard to believe that this court really wants to relitigate the second half of the 20th century, but we'll have an answer soon enough.
› Verified 4 days ago
The rate of readmission show you whether patients who were being treated regularly at DCI - South Lexington were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 22 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 35 |
| Readmission Rate: Lower Confidence Limit | 12 |
News Archive
Merck, today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion under accelerated assessment recommending approval of the investigational medicine VICTRELIS (boceprevir) for the treatment of chronic hepatitis C virus genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients with compensated liver disease who are previously untreated or who have failed previous therapy.
Why do patients opt for complementary and alternative therapies when they are ill? Is the relationship and communication between a patient and a practitioner as important in the treatment as the complementary treatments prescribed?
A team of scientists led by a researcher at the Case Western Reserve University School of Medicine is making strides to fight deadly metastatic breast cancer by combining nanotechnology with immunotherapy.
A Supreme Court decision to throw out health-care reform on Commerce Clause grounds could open up hundreds of other federal laws to legal challenge - starting with the Civil Rights Act. It's hard to believe that this court really wants to relitigate the second half of the 20th century, but we'll have an answer soon enough.
› Verified 4 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at DCI - South Lexington get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .82 (As Expected) |
| SIR: Upper Confidence Limit | 2.23 |
| SIR: Lower Confidence Limit | .21 |
News Archive
Merck, today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion under accelerated assessment recommending approval of the investigational medicine VICTRELIS (boceprevir) for the treatment of chronic hepatitis C virus genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients with compensated liver disease who are previously untreated or who have failed previous therapy.
Why do patients opt for complementary and alternative therapies when they are ill? Is the relationship and communication between a patient and a practitioner as important in the treatment as the complementary treatments prescribed?
A team of scientists led by a researcher at the Case Western Reserve University School of Medicine is making strides to fight deadly metastatic breast cancer by combining nanotechnology with immunotherapy.
A Supreme Court decision to throw out health-care reform on Commerce Clause grounds could open up hundreds of other federal laws to legal challenge - starting with the Civil Rights Act. It's hard to believe that this court really wants to relitigate the second half of the 20th century, but we'll have an answer soon enough.
› Verified 4 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether DCI - South Lexington's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 48 |
| Transfusion Rate in facility | 21.7 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 82.6 |
| Transfusion Rate: Lower Confidence Limit | 6.7 |
News Archive
Merck, today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion under accelerated assessment recommending approval of the investigational medicine VICTRELIS (boceprevir) for the treatment of chronic hepatitis C virus genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients with compensated liver disease who are previously untreated or who have failed previous therapy.
Why do patients opt for complementary and alternative therapies when they are ill? Is the relationship and communication between a patient and a practitioner as important in the treatment as the complementary treatments prescribed?
A team of scientists led by a researcher at the Case Western Reserve University School of Medicine is making strides to fight deadly metastatic breast cancer by combining nanotechnology with immunotherapy.
A Supreme Court decision to throw out health-care reform on Commerce Clause grounds could open up hundreds of other federal laws to legal challenge - starting with the Civil Rights Act. It's hard to believe that this court really wants to relitigate the second half of the 20th century, but we'll have an answer soon enough.
› Verified 4 days ago
The rate of mortality show you whether patients who were being treated regularly at DCI - South Lexington lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 242 |
| Mortality Rate in facility | 16.8 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 23.3 |
| Mortality Rate: Lower Confidence Limit | 11.8 |
News Archive
Merck, today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion under accelerated assessment recommending approval of the investigational medicine VICTRELIS (boceprevir) for the treatment of chronic hepatitis C virus genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients with compensated liver disease who are previously untreated or who have failed previous therapy.
Why do patients opt for complementary and alternative therapies when they are ill? Is the relationship and communication between a patient and a practitioner as important in the treatment as the complementary treatments prescribed?
A team of scientists led by a researcher at the Case Western Reserve University School of Medicine is making strides to fight deadly metastatic breast cancer by combining nanotechnology with immunotherapy.
A Supreme Court decision to throw out health-care reform on Commerce Clause grounds could open up hundreds of other federal laws to legal challenge - starting with the Civil Rights Act. It's hard to believe that this court really wants to relitigate the second half of the 20th century, but we'll have an answer soon enough.
› Verified 4 days ago
Kentucky Childrens Hospital Location: 800 Rose Street, Mn-109, Lexington, Kentucky, 40536 Phone: (859) 323-8965 |
DCI - South Lexington Location: 2374 Professional Heights Dr., Lexington, Kentucky, 40503 Phone: (859) 967-0400 |
Fmc- Lexington South Dialysis Location: 171 N Eagle Creek Dr Ste 110, Lexington, Kentucky, 40509 Phone: (859) 264-7775 |
FMC - Kentucky Renal Care Group - Lexington East Location: 1101 Winchester Rd., Suite 100, Lexington, Kentucky, 40505 Phone: (859) 225-4922 |
News Archive
Merck, today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion under accelerated assessment recommending approval of the investigational medicine VICTRELIS (boceprevir) for the treatment of chronic hepatitis C virus genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients with compensated liver disease who are previously untreated or who have failed previous therapy.
Why do patients opt for complementary and alternative therapies when they are ill? Is the relationship and communication between a patient and a practitioner as important in the treatment as the complementary treatments prescribed?
A team of scientists led by a researcher at the Case Western Reserve University School of Medicine is making strides to fight deadly metastatic breast cancer by combining nanotechnology with immunotherapy.
A Supreme Court decision to throw out health-care reform on Commerce Clause grounds could open up hundreds of other federal laws to legal challenge - starting with the Civil Rights Act. It's hard to believe that this court really wants to relitigate the second half of the 20th century, but we'll have an answer soon enough.
› Verified 4 days ago